shutterstock_1158780712.jpg

NASHVILLE

CONFERENCE

WEBCAST NOW AVAILABLE!

SOCIETY ENDORSEMENT 
 

**All times shown in Central Time

AGENDA
*Agenda is subject to change.

7:00 AM 

Breakfast & Registration

7:15 AM - 8:15 AM

Independent Symposium (Accredited) 

New Advances in NASH Diagnostics and Prognostics

Chronic Liver Disease Foundation 

8:30 AM – 8:40 AM

Welcome

Michael Vaezi, MD, PhD, MSc

SESSION I

8:40 AM – 9:05 AM

Refractory GERD:  Is it GERD and What Should You Do?

Michael Vaezi, MD, PhD, MSc 

9:05 AM – 9:30 AM

Barrett’s Esophagus: To Ablate or Not?

Ronnie Fass, MD

9:30 AM AM – 9:55 AM

The Impact of Opioid Use on Esophageal Symptoms and Motility

Michael Vaezi, MD, PhD, MSc 

9:55 AM – 10:15 AM

Q&A/Panel Discussion

10:15 AM – 10:30 AM

Break

SESSION II

10:30 AM – 11:00 AM

Viral Hepatitis B & C: Diagnosis, Management and Monitoring

Nancy Reau, MD 

11:00 AM – 11:30 AM

Managing Complications of Cirrhosis: Hepatic Encephalopathy and Hepatorenal Syndrome

Steven Flamm, MD

11:30 AM – 12:00 PM

Hepatocellular Carcinoma: Screening and Treatment Recommendations

Manhal Izzy, MD

12:00 PM – 12:15 PM

Q&A/Panel Discussion

12:15 PM – 12:45 PM

Lunch Break

12:45 PM – 1:45 PM

Product Theater (Non-Accredited)
8 Weeks: The Shortest Route to a Cure
Robert McClure, MD
Sponsored by: AbbVie

1:45 PM – 2:45 PM

Parallel Sessions (Select One)

  • Case Studies in Upper GI

  • Case Studies in Lower GI

  • Case Studies in Inflammatory Bowel Disease (IBD)

  • Case Studies in Chronic Liver Disease Including NAFLD/NASH

 

2:45 PM – 3:00 PM

Break

SESSION III

3:00 PM – 3:25 PM

Biologics and Small Molecule Therapy for IBD: Practical Approaches to Selecting Therapies

Anita Afzali, MD, MPH

3:25 PM – 3:50 PM

Colon Cancer Screening and Surveillance

Reid Ness, MD, MPH

3:50 PM – 4:15 PM

Pancreatic Cystic Lesions: What You Need to Know

Patrick Yachimski, MD

4:15 PM – 4:35 PM

Q&A/Panel Discussion

4:35 PM – 4:45 PM

Meeting Wrap-Up

Michael Vaezi, MD, PhD, MSc

 
 

FACULTY

Vaezi.png

Michael Vaezi, MD, PhD, MSc, FACG (Course Director)

Professor of Medicine and Otolaryngology
Associate Chief, Division of Gastroenterology,
Hepatology and Nutrition
Director, Clinical Research and Esophageal Center
Vanderbilt University Medical Center
Nashville, Tennessee

Anita Afzali, MD, MPH

Associate Professor of Medicine
Abercrombie & Fitch Endowed Chair in Inflammatory Bowel Disease
Medical Director, OSU Inflammatory Bowel Disease Center
Program Director, OSU Advanced Inflammatory Bowel Disease Fellowship
Division of Gastroenterology, Hepatology and Nutrition
The Ohio State University Wexner Medical Center
Columbus, Ohio

Steven Flamm, MD

Chief of Hepatology and Liver Transplantation Program
Professor of Medicine and Surgery
Northwestern Feinberg School of Medicine
Chicago, Illinois

Reid Ness, MD, MPH

Associate Professor of Medicine
Vanderbilt University Medical Center
Nashville, Tennessee

Patrick Yachimski, MD, MPH

Associate Professor of Medicine
Director of Pancreatobiliary Endoscopy
Division of Gastroenterology, Hepatology & Nutrition
Vanderbilt University Medical Center
Nashville, Tennessee

Ronnie Fass, MD

Professor of Medicine
Case Western Reserve University
Cleveland, Ohio

Manhal Izzy, MD

Assistant Professor Of Medicine
Vanderbilt University Medical Center
Nashville, Tennessee

Nancy Reau, MD

The Richard B. Capps Chair of Hepatology
Professor, Department of Internal Medicine,
Division of Digestive Diseases and Nutrition
Section Chief, Hepatology
Associate Director of Organ Transplantation
Rush University Medical Center
Chicago, Illinois

 

VENUE

Loews Vanderbilt

2100 West End Ave

Nashville, Tennessee 37203

loews-vanderbilt.jpg
 

COVID-19 SAFETY NOTICE

GALA remains diligent in ensuring that the safety and security of our attendees, speakers, and staff are a top priority while planning the conference. As we move ahead with planning the conference, GALA will continue to place high importance on facilitating measures that will ensure optimal health and sanitary conditions for everyone on site. COVID-19 state rules and regulations will be strictly followed.